About LUMINARY THERAPEUTICS, INC.
Luminary Therapeutics is a clinical-stage company developing innovative allogeneic cell therapies using its unique Gamma 2.0+ platform to target solid tumors and autoimmune disorders. The company aims to overcome key challenges in CAR T therapy, including antigen escape, limited tumor infiltration, and high production costs.
Developing allogeneic cell therapies using the Gamma 2.0+ platformDesigning Dual CAR architecture to target multiple cancer antigens in solid tumorsOptimizing costimulatory domain arrangements to prevent T cell exhaustionUtilizing the TcBuster transposon system for large genetic cargo capacityCreating BAFF ligand-based CARs to address antigen escape and reduce relapse rates
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LUMINARY THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.